달러 표시
Kuva Acquisition Commences Tender Offer To Purchase All Issued And Outstanding Shares Of Common Stock Of Lisata Therapeutics For $4.00/Shr In Cash At Closing, Plus One Non-Tradeable Contingent Value Right | 웨이프 WAPE